IO Biotech Inc (NASDAQ: IOBT) kicked off on Monday, down -12.54% from the previous trading day, before settling in for the closing price of $0.81. Over the past 52 weeks, IOBT has traded in a range of $0.32-$2.79.
Healthcare Sector giant saw their annual sales slid by -25.33% over the last five years. While this was happening, its average annual earnings per share was recorded 28.62%. With a float of $58.90 million, this company’s outstanding shares have now reached $69.69 million.
IO Biotech Inc (IOBT) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of IO Biotech Inc is 18.13%, while institutional ownership is 37.33%. The most recent insider transaction that took place on May 30 ’25, was worth 20,884. In this transaction Director of this company bought 15,000 shares at a rate of $1.39, taking the stock ownership to the 15,000 shares. Before that another transaction happened on Dec 23 ’24, when Company’s Chief Medical Officer bought 31,350 for $0.85, making the entire transaction worth $26,553. This insider now owns 31,350 shares in total.
IO Biotech Inc (IOBT) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.46 earnings per share (EPS), lower than consensus estimate (set at -0.38) by -0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 28.62% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 31.70% during the next five years compared to -25.33% drop over the previous five years of trading.
IO Biotech Inc (NASDAQ: IOBT) Trading Performance Indicators
Take a look at IO Biotech Inc’s (IOBT) current performance indicators. Last quarter, stock had a quick ratio of 2.01.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.34, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.44 in one year’s time.
Technical Analysis of IO Biotech Inc (IOBT)
Analysing the last 5-days average volume posted by the [IO Biotech Inc, IOBT], we can find that recorded value of 0.78 million was lower than the volume posted last year of 1.89 million. As of the previous 9 days, the stock’s Stochastic %D was 67.64%.
During the past 100 days, IO Biotech Inc’s (IOBT) raw stochastic average was set at 15.52%, which indicates a significant decrease from 40.51% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0807 in the past 14 days, which was lower than the 0.1586 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.7785, while its 200-day Moving Average is $1.2092. Now, the first resistance to watch is $0.7859. This is followed by the second major resistance level at $0.8654. The third major resistance level sits at $0.9309. If the price goes on to break the first support level at $0.6409, it is likely to go to the next support level at $0.5754. Now, if the price goes above the second support level, the third support stands at $0.4959.
IO Biotech Inc (NASDAQ: IOBT) Key Stats
The company with the Market Capitalisation of 50.82 million has total of 71,949K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -95,490 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -8,380 K.
